ASX healthcare giant rallies despite a fall in profits
Stocks
ASX healthcare giant rallies despite a fall in profits
Easing investor concerns and signalling a return to growth.
ASX healthcare share remains cheap despite mixed earnings result
Stocks
ASX healthcare share remains cheap despite mixed earnings result
Shares in Aussie listed healthcare name undervalued post earnings.
Wide moat healthcare leader remains undervalued
Stocks
Wide moat healthcare leader remains undervalued
ASX healthcare giant expected to see uptick in demand from emerging markets.
Undervalued ASX healthcare provider
Stocks
Undervalued ASX healthcare provider
Solid demand profile for global leader.
Market Minute: Reporting Season, Part 2
Markets
Market Minute: Reporting Season, Part 2
Equity Market Strategist Lochlan Halloway is back with Part 2 of the Reporting Season update, with more upgrades than average and big share price...
Market Minute: Reporting Season, Part 1
Markets
Market Minute: Reporting Season, Part 1
Join Equity Market Strategist Lochlan Halloway in this week’s Market Minute, where he’s covering the first stage of Reporting Season.
Long winter for retailers starting to thaw
Markets
Long winter for retailers starting to thaw
We’ve seen consumer sentiment recover from the extreme lows of the last few years; conditions are ripe for a retail rebound.
James Hardie and Soul Patts deals under the microscope
Markets
James Hardie and Soul Patts deals under the microscope
Two deals, and two vastly different verdicts from the market. Why?
How we factor tariff uncertainty into equity valuations
Stocks
How we factor tariff uncertainty into equity valuations
We recognise that the short-term macroeconomic backdrop can be very important for certain industries, but long-term fundamentals are almost always...
First impressions: US tariffs on Australian equities
Stocks
First impressions: US tariffs on Australian equities
Direct impact modest but global growth and inflation are wildcards.
of 3
Viewing 1 to 10 of 27